Form 8-K - Current report:
SEC Accession No. 0001731122-25-001625
Filing Date
2025-12-03
Accepted
2025-12-02 21:31:35
Documents
15
Period of Report
2025-12-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e7056_8-k.htm   iXBRL 8-K 37252
2 EXHIBIT 1.1 e7056_ex1-1.htm EX-1.1 229574
3 EXHIBIT 5.1 e7056_ex5-1.htm EX-5.1 10971
4 GRAPHIC image_010.jpg GRAPHIC 33592
  Complete submission text file 0001731122-25-001625.txt   556700

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lnai-20251202.xsd EX-101.SCH 3029
6 XBRL LABEL FILE lnai-20251202_lab.xml EX-101.LAB 34239
7 XBRL PRESENTATION FILE lnai-20251202_pre.xml EX-101.PRE 22368
17 EXTRACTED XBRL INSTANCE DOCUMENT e7056_8-k_htm.xml XML 3693
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
Lunai Bioworks Inc. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-38758 | Film No.: 251544815
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)